STOCK TITAN

[8-K/A] Fresh Vine Wine, Inc. Amends Material Event Report

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
8-K/A
Rhea-AI Filing Summary

Cryoport (CYRX) Form 4 filing: On 07/24/2025 President & CEO Jerrell Shelton exercised 25,000 stock options at a $5 strike price (transaction code M) and retained every share. His direct common-stock holdings rose to 1,012,419 shares. The option grant, issued in 2015, vested monthly over four years; 50,000 options remain outstanding after the exercise. No shares were sold, representing an estimated $125,000 cash outlay and a modest increase in insider ownership. The move appears to be routine compensation-related activity rather than a strategic shift, yet the additional personal investment can be viewed as a sign of management confidence.

Deposito Form 4 di Cryoport (CYRX): Il 24/07/2025 il Presidente e CEO Jerrell Shelton ha esercitato 25.000 opzioni su azioni con un prezzo di esercizio di 5$ (codice transazione M) e ha mantenuto tutte le azioni. La sua partecipazione diretta in azioni ordinarie è salita a 1.012.419 azioni. La concessione delle opzioni, emessa nel 2015, si è maturata mensilmente in quattro anni; dopo l'esercizio rimangono 50.000 opzioni ancora in circolazione. Nessuna azione è stata venduta, rappresentando una spesa stimata di 125.000$ in contanti e un modesto aumento della proprietà interna. L'operazione sembra essere un'attività di compensazione di routine piuttosto che un cambiamento strategico, ma l'investimento personale aggiuntivo può essere interpretato come un segnale di fiducia della dirigenza.

Presentación Formulario 4 de Cryoport (CYRX): El 24/07/2025, el Presidente y CEO Jerrell Shelton ejerció 25,000 opciones sobre acciones a un precio de ejercicio de 5$ (código de transacción M) y retuvo todas las acciones. Su participación directa en acciones comunes aumentó a 1,012,419 acciones. La concesión de opciones, emitida en 2015, se adquirió mensualmente durante cuatro años; tras el ejercicio quedan 50,000 opciones pendientes. No se vendió ninguna acción, representando un desembolso estimado de 125,000$ en efectivo y un modesto incremento en la propiedad interna. La operación parece ser una actividad rutinaria relacionada con la compensación más que un cambio estratégico, aunque la inversión personal adicional puede interpretarse como una señal de confianza de la gerencia.

Cryoport (CYRX) Form 4 제출: 2025년 7월 24일, 사장 겸 CEO인 Jerrell Shelton이 행사가격 5달러로 25,000주 스톡옵션을 행사했으며(거래 코드 M), 모든 주식을 보유했습니다. 그의 직접 보유 보통주는 1,012,419주로 증가했습니다. 2015년에 부여된 옵션은 4년간 매월 권리가 발생했으며, 행사 후 50,000주 옵션이 남아 있습니다. 주식은 판매되지 않았으며, 이는 약 125,000달러 현금 지출과 내부자 소유권의 소폭 증가를 의미합니다. 이번 조치는 전략적 변화보다는 보상 관련 일상적 활동으로 보이나, 추가 개인 투자로 경영진의 신뢰를 나타내는 신호로 해석될 수 있습니다.

Dépôt du formulaire 4 de Cryoport (CYRX) : Le 24/07/2025, le Président et CEO Jerrell Shelton a exercé 25 000 options d'achat d'actions à un prix d'exercice de 5$ (code transaction M) et a conservé toutes les actions. Sa détention directe d'actions ordinaires est passée à 1 012 419 actions. La concession d'options, accordée en 2015, s'est acquise mensuellement sur quatre ans ; après l'exercice, 50 000 options restent en circulation. Aucune action n'a été vendue, représentant une dépense estimée à 125 000$ en liquidités et une légère augmentation de la participation des initiés. Ce mouvement semble être une activité de rémunération de routine plutôt qu'un changement stratégique, mais cet investissement personnel supplémentaire peut être interprété comme un signe de confiance de la direction.

Cryoport (CYRX) Form 4 Einreichung: Am 24.07.2025 übte Präsident und CEO Jerrell Shelton 25.000 Aktienoptionen zu einem Ausübungspreis von 5$ aus (Transaktionscode M) und behielt alle Aktien. Sein direkter Bestand an Stammaktien stieg auf 1.012.419 Aktien. Der Optionszuteilung, die 2015 gewährt wurde, erfolgte monatlich über vier Jahre; nach der Ausübung sind noch 50.000 Optionen offen. Es wurden keine Aktien verkauft, was einen geschätzten Baraufwand von 125.000$ und eine moderate Steigerung des Insiderbesitzes darstellt. Die Maßnahme scheint eine routinemäßige, vergütungsbezogene Aktivität zu sein und keine strategische Änderung, doch die zusätzliche persönliche Investition kann als Zeichen des Vertrauens des Managements gewertet werden.

Positive
  • CEO Jerrell Shelton increased his direct ownership by 25,000 shares, indicating continued confidence in CYRX.
Negative
  • None.

Insights

TL;DR: Routine option exercise; modest buy signals steady insider confidence, limited market impact.

The CEO converted 25 k in-the-money options at $5 and kept the resulting shares, lifting his direct stake to approximately one million. Because there was no simultaneous sale, the filing reflects a net purchase of roughly $125 k. The share count involved is small relative to Cryoport’s float and average volume, so price impact should be minimal. Investors may read the move as incremental alignment of management and shareholder interests, but it does not alter earnings outlook or capital structure.

Deposito Form 4 di Cryoport (CYRX): Il 24/07/2025 il Presidente e CEO Jerrell Shelton ha esercitato 25.000 opzioni su azioni con un prezzo di esercizio di 5$ (codice transazione M) e ha mantenuto tutte le azioni. La sua partecipazione diretta in azioni ordinarie è salita a 1.012.419 azioni. La concessione delle opzioni, emessa nel 2015, si è maturata mensilmente in quattro anni; dopo l'esercizio rimangono 50.000 opzioni ancora in circolazione. Nessuna azione è stata venduta, rappresentando una spesa stimata di 125.000$ in contanti e un modesto aumento della proprietà interna. L'operazione sembra essere un'attività di compensazione di routine piuttosto che un cambiamento strategico, ma l'investimento personale aggiuntivo può essere interpretato come un segnale di fiducia della dirigenza.

Presentación Formulario 4 de Cryoport (CYRX): El 24/07/2025, el Presidente y CEO Jerrell Shelton ejerció 25,000 opciones sobre acciones a un precio de ejercicio de 5$ (código de transacción M) y retuvo todas las acciones. Su participación directa en acciones comunes aumentó a 1,012,419 acciones. La concesión de opciones, emitida en 2015, se adquirió mensualmente durante cuatro años; tras el ejercicio quedan 50,000 opciones pendientes. No se vendió ninguna acción, representando un desembolso estimado de 125,000$ en efectivo y un modesto incremento en la propiedad interna. La operación parece ser una actividad rutinaria relacionada con la compensación más que un cambio estratégico, aunque la inversión personal adicional puede interpretarse como una señal de confianza de la gerencia.

Cryoport (CYRX) Form 4 제출: 2025년 7월 24일, 사장 겸 CEO인 Jerrell Shelton이 행사가격 5달러로 25,000주 스톡옵션을 행사했으며(거래 코드 M), 모든 주식을 보유했습니다. 그의 직접 보유 보통주는 1,012,419주로 증가했습니다. 2015년에 부여된 옵션은 4년간 매월 권리가 발생했으며, 행사 후 50,000주 옵션이 남아 있습니다. 주식은 판매되지 않았으며, 이는 약 125,000달러 현금 지출과 내부자 소유권의 소폭 증가를 의미합니다. 이번 조치는 전략적 변화보다는 보상 관련 일상적 활동으로 보이나, 추가 개인 투자로 경영진의 신뢰를 나타내는 신호로 해석될 수 있습니다.

Dépôt du formulaire 4 de Cryoport (CYRX) : Le 24/07/2025, le Président et CEO Jerrell Shelton a exercé 25 000 options d'achat d'actions à un prix d'exercice de 5$ (code transaction M) et a conservé toutes les actions. Sa détention directe d'actions ordinaires est passée à 1 012 419 actions. La concession d'options, accordée en 2015, s'est acquise mensuellement sur quatre ans ; après l'exercice, 50 000 options restent en circulation. Aucune action n'a été vendue, représentant une dépense estimée à 125 000$ en liquidités et une légère augmentation de la participation des initiés. Ce mouvement semble être une activité de rémunération de routine plutôt qu'un changement stratégique, mais cet investissement personnel supplémentaire peut être interprété comme un signe de confiance de la direction.

Cryoport (CYRX) Form 4 Einreichung: Am 24.07.2025 übte Präsident und CEO Jerrell Shelton 25.000 Aktienoptionen zu einem Ausübungspreis von 5$ aus (Transaktionscode M) und behielt alle Aktien. Sein direkter Bestand an Stammaktien stieg auf 1.012.419 Aktien. Der Optionszuteilung, die 2015 gewährt wurde, erfolgte monatlich über vier Jahre; nach der Ausübung sind noch 50.000 Optionen offen. Es wurden keine Aktien verkauft, was einen geschätzten Baraufwand von 125.000$ und eine moderate Steigerung des Insiderbesitzes darstellt. Die Maßnahme scheint eine routinemäßige, vergütungsbezogene Aktivität zu sein und keine strategische Änderung, doch die zusätzliche persönliche Investition kann als Zeichen des Vertrauens des Managements gewertet werden.

true 0001880343 0001880343 2025-07-21 2025-07-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K/A

 

 

CURRENT REPORT

Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 21, 2025

 

AMAZE HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

 

Nevada   001-41147   87-3905007
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

 

2901 West Coast Highway, Suite 200

Newport Beach, CA

  92663
(Address of principal executive offices)   (Zip Code)

 

 

(855) 766-9463

Registrant’s telephone number, including area code

 

Fresh Vine Wine, Inc.

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, par value $0.001 per share   AMZE   NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

   
   

 

Explanatory Note

 

This Amendment (the “Amendment”) to the Current Report on Form 8-K filed with the SEC on July 25, 2025 (the “Original 8-K”) is being filed to correct the number of shares of common stock issued during the period from July 7 to July 23. The Original 8-K inadvertently included the total aggregate number of shares issued pursuant to the Purchase Agreement. This Amendment corrects the number of shares issued from July 7 through July 23, 2025 to 329,040 shares of common stock. No other changes have been made to the Original 8-K.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

From July 7 through July 23, 2025, Amaze Holdings, Inc. (f/k/a Fresh Vine Wine, Inc.) (the “Company”) issued and sold to C/M Capital Master Fund, LP (the “Purchaser”) a total of 329,040 shares of common stock for an aggregate purchase price of $2,601,011, pursuant to that certain securities purchase agreement (the “Purchase Agreement”) dated as of May 6, 2025 by and between the Company and the Purchaser. The Purchase Agreement was previously reported in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 7, 2025.

 

In connection with those sales, the Company also issued a total of 2468 shares of common stock to the Purchaser as commitment shares, pursuant to the terms of the Purchase Agreement.

 

The shares of common stock were offered and sold to the Purchaser in reliance upon exemptions from registration pursuant to Section 4(a)(2) under the Securities Act of 1933, as amended, and/or Rule 506(b) of Regulation D promulgated thereunder, as transactions by an issuer not involving any public offering.

 

This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy any of these securities. The offer or sale by the Company of the securities is not being registered under the Securities Act or any state securities laws and, therefore, such securities may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from the registration requirements.

 

 

   
   

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: July 28, 2025    
     
  AMAZE HOLDINGS, INC.
     
  By: /s/ Aaron Day
  Name: Aaron Day
  Title: Chief Executive Officer

 

 

 

FAQ

What insider activity was reported for CYRX on 07/24/2025?

CEO Jerrell Shelton exercised 25,000 stock options at $5 and kept all resulting shares.

How many Cryoport shares does the CEO now own?

After the transaction, Shelton holds 1,012,419 shares directly.

What was the exercise price of the options?

The options were exercised at $5 per share.

Did the CEO sell any CYRX shares after exercising the options?

No. All 25,000 acquired shares were retained.

How many options remain outstanding for Jerrell Shelton?

He still holds 50,000 stock options after the reported exercise.
Fresh Vine Wine Inc

NYSE:VINE

VINE Rankings

VINE Latest News

VINE Latest SEC Filings

VINE Stock Data

11.58M
11.56M
34.91%
2.78%
1.16%
Beverages - Wineries & Distilleries
Retail-eating Places
Link
United States
CHARLOTTE